Peptimmune
Latest round
- Series D
Last raised
- Jul 2008
Total raised
- $79M
Investors
- 9
About Peptimmune
Peptimmune, Inc. is based in US and operates as a clinical stage biotechnology company focused on chronic autoimmune and metabolic disorders.
Who invested in Peptimmune
9 investors across 4 rounds
See all investors in Peptimmune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Peptimmune
Who invested in Peptimmune?
Peptimmune has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Peptimmune raised?
Peptimmune has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Peptimmune last raise money?
Peptimmune's most recent round on record is a Series D, in Jul 2008.
What does Peptimmune do?
Peptimmune is a biotechnology company.
Where is Peptimmune headquartered?
Peptimmune is headquartered in Cambridge, US.
Which VCs invest in companies like Peptimmune?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Peptimmune's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Peptimmune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.